Skip to content
Menu
About
Platform
Programs
News
Careers
Contact
News
News Release
Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman
Announcement
Ton Schumacher, member of Scenic’s Scientific Advisory Board has been awarded the Jeantet-Collen Prize for Translational Medicine
Coverage
Scenic’s Chief Scientific Officer Sebastian Nijman explains why genetic modifiers are an untapped source of drug targets
News Release
Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech
Announcement
Scenic founders publish paper in Science Signaling
News Release
Scenic Biotech Appoints Oscar Izeboud as Chief Executive Officer
News Release
Scenic Biotech Awarded €3.1 million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program
Coverage
Interview with Scenic’s founder Thijn Brummelkamp in Labiotech
News Release
Scenic’s platform technology patent receives notice of allowance
Announcement
Scenic’s advisor Ton Schumacher identifies a modifier of the CD47 “don’t eat me” checkpoint
Announcement
Eurostars Grant awarded to Scenic
Announcement
Scenic appoints Ulrich Grau as Chairman of the Board